[
  {
    "title": "【龙虎榜】赛隆药业12月21日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/12/21180037228944.shtml",
    "datetime": "2022-12-21 18:00:17",
    "code": "002898"
  },
  {
    "title": "医药股再度回调，赛隆药业跌停，永太科技、亨迪药业等跌超5%",
    "href": "http://stock.jrj.com.cn/2022/12/20093937224637.shtml",
    "datetime": "2022-12-20 09:39:43",
    "code": "002898"
  },
  {
    "title": "【龙虎榜】赛隆药业12月15日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/12/15180037215689.shtml",
    "datetime": "2022-12-15 18:00:11",
    "code": "002898"
  },
  {
    "title": "赛隆药业2名股东合计减持152万股 套现合计1923.58万 2022年前三季度公司净利169.7万",
    "href": "http://stock.jrj.com.cn/2022/12/14201237213065.shtml",
    "datetime": "2022-12-14 20:12:15",
    "code": "002898"
  },
  {
    "title": "赛隆药业(002898.SZ)：唐霖和赛隆聚智共完成减持152万股",
    "href": "http://stock.jrj.com.cn/2022/12/14164537212201.shtml",
    "datetime": "2022-12-14 16:45:55",
    "code": "002898"
  },
  {
    "title": "赛隆药业股东赛隆聚智质押556万股 用于偿还债务、股权投资",
    "href": "http://stock.jrj.com.cn/2022/12/09191237202533.shtml",
    "datetime": "2022-12-09 19:12:05",
    "code": "002898"
  },
  {
    "title": "【龙虎榜】赛隆药业12月1日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/12/01180037182081.shtml",
    "datetime": "2022-12-01 18:00:19",
    "code": "002898"
  },
  {
    "title": "【龙虎榜】赛隆药业11月30日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/11/30180037178755.shtml",
    "datetime": "2022-11-30 18:00:07",
    "code": "002898"
  },
  {
    "title": "【龙虎榜】赛隆药业11月29日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/11/29180037175043.shtml",
    "datetime": "2022-11-29 18:00:06",
    "code": "002898"
  },
  {
    "title": "A股异动 | 赛隆药业(002898.SZ)跌逾7% 赛隆聚智以集中竞价减持1.05%股份",
    "href": "http://stock.jrj.com.cn/2022/11/29135737174012.shtml",
    "datetime": "2022-11-29 13:57:19",
    "code": "002898"
  },
  {
    "title": "实控人大股东“组团”减持 赛隆药业研发投入无“亮点 业绩何时有起色？",
    "href": "http://stock.jrj.com.cn/2022/11/28080237169964.shtml",
    "datetime": "2022-11-28 08:02:00",
    "code": "002898"
  },
  {
    "title": "赛隆药业(002898.SZ)：赛隆聚智以集中竞价减持1.05%的股份",
    "href": "http://stock.jrj.com.cn/2022/11/25183737167690.shtml",
    "datetime": "2022-11-25 18:37:00",
    "code": "002898"
  },
  {
    "title": "【龙虎榜】赛隆药业11月25日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/11/25180037167457.shtml",
    "datetime": "2022-11-25 18:00:06",
    "code": "002898"
  },
  {
    "title": "赛隆药业(002898.SZ)：赛隆聚智已减持0.51%的股份",
    "href": "http://stock.jrj.com.cn/2022/11/24184637164593.shtml",
    "datetime": "2022-11-24 18:46:50",
    "code": "002898"
  },
  {
    "title": "赛隆药业(002898.SZ)第三季度净利64.54万元 同比下降72.94%",
    "href": "http://stock.jrj.com.cn/2022/10/28211437095696.shtml",
    "datetime": "2022-10-28 21:14:39",
    "code": "002898"
  },
  {
    "title": "【龙虎榜】赛隆药业10月25日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/10/25180037082316.shtml",
    "datetime": "2022-10-25 18:00:13",
    "code": "002898"
  },
  {
    "title": "【龙虎榜】赛隆药业10月21日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/10/21180037073976.shtml",
    "datetime": "2022-10-21 18:00:18",
    "code": "002898"
  },
  {
    "title": "赛隆药业(002898.SZ)：减持期过半 唐霖、赛隆聚智已合计减持70万股",
    "href": "http://stock.jrj.com.cn/2022/09/14161836994169.shtml",
    "datetime": "2022-09-14 16:18:23",
    "code": "002898"
  },
  {
    "title": "赛隆药业(002898.SZ)半年度净利润105.17万元 同比下降88.83%",
    "href": "http://stock.jrj.com.cn/2022/08/25213336937483.shtml",
    "datetime": "2022-08-25 21:33:07",
    "code": "002898"
  },
  {
    "title": "赛隆药业(002898.SZ)：阿加曲班注射液通过一致性评价",
    "href": "http://stock.jrj.com.cn/2022/07/18171236821664.shtml",
    "datetime": "2022-07-18 17:12:22",
    "code": "002898"
  },
  {
    "title": "赛隆药业2022年上半年预计净利80万-120万同比下降87%-92% 研发费用增加",
    "href": "http://stock.jrj.com.cn/2022/07/14191036812436.shtml",
    "datetime": "2022-07-14 19:10:54",
    "code": "002898"
  },
  {
    "title": "赛隆药业(002898.SZ)：3个产品拟中标集采",
    "href": "http://stock.jrj.com.cn/2022/07/12220436805022.shtml",
    "datetime": "2022-07-12 22:04:52",
    "code": "002898"
  },
  {
    "title": "赛隆药业：股东唐霖及赛隆聚智拟合计减持不超2%公司股份",
    "href": "http://stock.jrj.com.cn/2022/05/25142436677280.shtml",
    "datetime": "2022-05-25 14:24:40",
    "code": "002898"
  },
  {
    "title": "赛隆药业(002898.SZ)： 唐霖及赛隆聚智拟合计减持不超2%股份",
    "href": "http://stock.jrj.com.cn/2022/05/25114336676865.shtml",
    "datetime": "2022-05-25 11:43:16",
    "code": "002898"
  },
  {
    "title": "赛隆药业2022年第一季度净利128.07万同比下滑37.93% 财务费用增长",
    "href": "http://stock.jrj.com.cn/2022/05/03115036541872.shtml",
    "datetime": "2022-05-03 11:50:52",
    "code": "002898"
  },
  {
    "title": "赛隆药业2021年亏损2334.14万同比亏损减少 董事长蔡南桂薪酬33.72万",
    "href": "http://stock.jrj.com.cn/2022/04/27183136485232.shtml",
    "datetime": "2022-04-27 18:31:06",
    "code": "002898"
  },
  {
    "title": "赛隆药业(002898.SZ)2021年度净亏损2334.14万元",
    "href": "http://stock.jrj.com.cn/2022/04/26223736479157.shtml",
    "datetime": "2022-04-26 22:37:25",
    "code": "002898"
  },
  {
    "title": "赛隆药业(002898.SZ)一季度净利润128.09万元 同比下降37.93%",
    "href": "http://stock.jrj.com.cn/2022/04/26223436479160.shtml",
    "datetime": "2022-04-26 22:34:07",
    "code": "002898"
  },
  {
    "title": "赛隆药业(002898.SZ)：注射用替加环素和注射用胸腺法新通过一致性评价",
    "href": "http://stock.jrj.com.cn/2022/04/15160636344703.shtml",
    "datetime": "2022-04-15 16:06:42",
    "code": "002898"
  },
  {
    "title": "【龙虎榜】赛隆药业3月25日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/03/25180035123968.shtml",
    "datetime": "2022-03-25 18:00:06",
    "code": "002898"
  },
  {
    "title": "【龙虎榜】赛隆药业3月24日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/03/24180034911882.shtml",
    "datetime": "2022-03-24 18:00:00",
    "code": "002898"
  },
  {
    "title": "赛隆药业股东赛隆聚智减持88万股 套现1142.24万 2021年公司亏损875万-1750万",
    "href": "http://stock.jrj.com.cn/2022/03/11191234815179.shtml",
    "datetime": "2022-03-11 19:12:00",
    "code": "002898"
  },
  {
    "title": "赛隆药业(002898.SZ)：赛隆聚智累计减持1.08%股份",
    "href": "http://stock.jrj.com.cn/2022/03/11162834814016.shtml",
    "datetime": "2022-03-11 16:28:32",
    "code": "002898"
  },
  {
    "title": "赛隆药业(002898.SZ)：氨甲环酸注射液通过一致性评价 并新增5ml:0.5g规格",
    "href": "http://stock.jrj.com.cn/2022/03/11162534814004.shtml",
    "datetime": "2022-03-11 16:25:45",
    "code": "002898"
  },
  {
    "title": "赛隆药业(002898.SZ)2021年度预亏875万–1750万元",
    "href": "http://stock.jrj.com.cn/2022/02/03134834279204.shtml",
    "datetime": "2022-02-03 13:48:11",
    "code": "002898"
  },
  {
    "title": "赛隆药业2021年预计亏损875万-1750万同比亏损减少 相关市场及销售活动稳步开展",
    "href": "http://stock.jrj.com.cn/2022/01/29155234257290.shtml",
    "datetime": "2022-01-29 15:52:46",
    "code": "002898"
  },
  {
    "title": "【龙虎榜】赛隆药业1月25日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/01/25180034213051.shtml",
    "datetime": "2022-01-25 18:00:12",
    "code": "002898"
  },
  {
    "title": "【龙虎榜】赛隆药业1月19日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/01/19180034174790.shtml",
    "datetime": "2022-01-19 18:00:01",
    "code": "002898"
  },
  {
    "title": "【龙虎榜】赛隆药业1月18日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/01/18180034170430.shtml",
    "datetime": "2022-01-18 18:00:34",
    "code": "002898"
  },
  {
    "title": "赛隆药业(002898.SZ)：注射用帕瑞昔布钠获得药品补充申请批准通知书",
    "href": "http://stock.jrj.com.cn/2022/01/18155334169709.shtml",
    "datetime": "2022-01-18 15:53:31",
    "code": "002898"
  },
  {
    "title": "【龙虎榜】赛隆药业1月14日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/01/14180034158444.shtml",
    "datetime": "2022-01-14 18:00:34",
    "code": "002898"
  },
  {
    "title": "【龙虎榜】赛隆药业1月13日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/01/13180034154791.shtml",
    "datetime": "2022-01-13 18:00:45",
    "code": "002898"
  },
  {
    "title": "【龙虎榜】赛隆药业1月11日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/01/11180034146819.shtml",
    "datetime": "2022-01-11 18:00:01",
    "code": "002898"
  },
  {
    "title": "赛隆药业(002898.SZ)：米力农注射液获得药品补充申请批准通知书",
    "href": "http://stock.jrj.com.cn/2022/01/10155334141301.shtml",
    "datetime": "2022-01-10 15:53:53",
    "code": "002898"
  },
  {
    "title": "赛隆药业(002898.SZ)：减持期过半 赛隆聚智未减持股份",
    "href": "http://stock.jrj.com.cn/2021/12/22180934048219.shtml",
    "datetime": "2021-12-22 18:09:03",
    "code": "002898"
  },
  {
    "title": "赛隆药业(002898.SZ)：控股股东蔡南桂解质583万股",
    "href": "http://stock.jrj.com.cn/2021/12/22180734048198.shtml",
    "datetime": "2021-12-22 18:07:11",
    "code": "002898"
  },
  {
    "title": "赛隆药业(002898.SZ)：赛隆聚智解除质押1065万股",
    "href": "http://stock.jrj.com.cn/2021/11/02175333804155.shtml",
    "datetime": "2021-11-02 17:53:42",
    "code": "002898"
  },
  {
    "title": "赛隆药业：控股股东蔡南桂所持1800万股质押",
    "href": "http://stock.jrj.com.cn/2021/10/29162433777800.shtml",
    "datetime": "2021-10-29 16:24:45",
    "code": "002898"
  },
  {
    "title": "赛隆药业(002898.SZ)：前三季度净利升154.71%至1180.10万元",
    "href": "http://stock.jrj.com.cn/2021/10/26202833756852.shtml",
    "datetime": "2021-10-26 20:28:55",
    "code": "002898"
  },
  {
    "title": "赛隆药业(002898.SZ)：前三季度预盈1000万元-1300万元 同比扭亏",
    "href": "http://stock.jrj.com.cn/2021/10/14165633691338.shtml",
    "datetime": "2021-10-14 16:56:13",
    "code": "002898"
  },
  {
    "title": "赛隆药业股东赛隆聚智减持102.02万股 套现1007.23万 上半年公司净利941.58万",
    "href": "http://stock.jrj.com.cn/2021/09/08194933405610.shtml",
    "datetime": "2021-09-08 19:49:03",
    "code": "002898"
  },
  {
    "title": "赛隆药业：注射用泮托拉唑钠通过一致性评价 有助于增强公司在消化领域竞争力",
    "href": "http://stock.jrj.com.cn/2021/09/08152033404195.shtml",
    "datetime": "2021-09-08 15:20:53",
    "code": "002898"
  },
  {
    "title": "赛隆药业(002898.SZ)：股东赛隆聚智大宗交易减持102.02万股",
    "href": "http://stock.jrj.com.cn/2021/09/08115833403178.shtml",
    "datetime": "2021-09-08 11:58:27",
    "code": "002898"
  },
  {
    "title": "赛隆药业(002898.SZ)：注射用泮托拉唑钠通过一致性评价",
    "href": "http://stock.jrj.com.cn/2021/09/08115233403170.shtml",
    "datetime": "2021-09-08 11:52:56",
    "code": "002898"
  },
  {
    "title": "赛隆药业完成工商变更登记 更名为赛隆药业集团股份有限公司",
    "href": "http://stock.jrj.com.cn/2021/09/03134633379409.shtml",
    "datetime": "2021-09-03 13:46:15",
    "code": "002898"
  },
  {
    "title": "赛隆药业(002898.SZ)：控股股东蔡南桂解押880万股",
    "href": "http://stock.jrj.com.cn/2021/08/31214633363754.shtml",
    "datetime": "2021-08-31 21:46:24",
    "code": "002898"
  },
  {
    "title": "赛隆药业：控股股东蔡南桂所持880万股解除质押",
    "href": "http://stock.jrj.com.cn/2021/08/31172033362394.shtml",
    "datetime": "2021-08-31 17:20:28",
    "code": "002898"
  },
  {
    "title": "赛隆药业股东赛隆聚智拟减持不超176万股公司股份 上半年公司净利941.58万",
    "href": "http://stock.jrj.com.cn/2021/08/30211533355193.shtml",
    "datetime": "2021-08-30 21:15:48",
    "code": "002898"
  },
  {
    "title": "赛隆药业(002898.SZ)：持股10.61%股东赛隆聚智拟减持不超1%股份",
    "href": "http://stock.jrj.com.cn/2021/08/30114633350891.shtml",
    "datetime": "2021-08-30 11:46:00",
    "code": "002898"
  },
  {
    "title": "赛隆药业(002898.SZ)半年度业绩扭亏为盈至941.58万元",
    "href": "http://stock.jrj.com.cn/2021/08/25213133319052.shtml",
    "datetime": "2021-08-25 21:31:12",
    "code": "002898"
  },
  {
    "title": "赛隆药业2021年半年度净利941.58万元 同比扭亏为盈",
    "href": "http://stock.jrj.com.cn/2021/08/25202033318593.shtml",
    "datetime": "2021-08-25 20:20:39",
    "code": "002898"
  },
  {
    "title": "赛隆药业：拟变更公司名称为“赛隆药业集团股份有限公司”",
    "href": "http://stock.jrj.com.cn/2021/08/10154733231690.shtml",
    "datetime": "2021-08-10 15:47:15",
    "code": "002898"
  },
  {
    "title": "赛隆药业(002898.SZ)拟更名为“赛隆药业集团股份有限公司”",
    "href": "http://stock.jrj.com.cn/2021/08/10115233230771.shtml",
    "datetime": "2021-08-10 11:52:07",
    "code": "002898"
  },
  {
    "title": "赛隆药业(002898.SZ)：预计上半年净利600万元-900万元 同比扭亏为盈",
    "href": "http://stock.jrj.com.cn/2021/07/14210333096670.shtml",
    "datetime": "2021-07-14 21:03:51",
    "code": "002898"
  },
  {
    "title": "赛隆药业：固体口服制剂暂未上市销售",
    "href": "http://stock.jrj.com.cn/2021/06/08143032893111.shtml",
    "datetime": "2021-06-08 14:30:28",
    "code": "002898"
  },
  {
    "title": "赛隆药业(002898.SZ)：注射用奥美拉唑钠通过一致性评价",
    "href": "http://stock.jrj.com.cn/2021/05/24155632810678.shtml",
    "datetime": "2021-05-24 15:56:50",
    "code": "002898"
  },
  {
    "title": "赛隆药业(002898.SZ)：进一步聚焦主业 拟转让湖南胜隆置业100%股权",
    "href": "http://stock.jrj.com.cn/2021/05/17194932770995.shtml",
    "datetime": "2021-05-17 19:49:58",
    "code": "002898"
  },
  {
    "title": "赛隆药业：公司现有属于第一类医疗器械的医用冷敷贴产品",
    "href": "http://stock.jrj.com.cn/2021/04/30065032484026.shtml",
    "datetime": "2021-04-30 06:50:37",
    "code": "002898"
  },
  {
    "title": "赛隆药业(002898.SZ)一季度实现净利206.35万元",
    "href": "http://stock.jrj.com.cn/2021/04/29220732482915.shtml",
    "datetime": "2021-04-29 22:07:51",
    "code": "002898"
  },
  {
    "title": "赛隆药业2021年第一季度预计净利180万-270万 新产品销售情况向好",
    "href": "http://stock.jrj.com.cn/2021/04/18094532392529.shtml",
    "datetime": "2021-04-18 09:45:45",
    "code": "002898"
  },
  {
    "title": "赛隆药业2020年度亏损6272万由盈转亏 获批新产品市场导入需要周期较长",
    "href": "http://stock.jrj.com.cn/2021/02/26223232035836.shtml",
    "datetime": "2021-02-26 22:32:43",
    "code": "002898"
  },
  {
    "title": "赛隆药业(002898.SZ)业绩快报：2020年度净亏损6271.62万元",
    "href": "http://stock.jrj.com.cn/2021/02/26200432034988.shtml",
    "datetime": "2021-02-26 20:04:33",
    "code": "002898"
  },
  {
    "title": "赛隆药业控股股东蔡南桂质押1720万股 用于补充质押",
    "href": "http://stock.jrj.com.cn/2021/02/04220531851111.shtml",
    "datetime": "2021-02-04 22:05:01",
    "code": "002898"
  },
  {
    "title": "赛隆药业(002898.SZ)：控股股东补充质押1720万股",
    "href": "http://stock.jrj.com.cn/2021/02/04183331850002.shtml",
    "datetime": "2021-02-04 18:33:30",
    "code": "002898"
  },
  {
    "title": "赛隆药业(002898.SZ)：股东赛隆聚智补充质押200万股",
    "href": "http://stock.jrj.com.cn/2021/02/04183231849998.shtml",
    "datetime": "2021-02-04 18:32:40",
    "code": "002898"
  },
  {
    "title": "赛隆药业2020年预计亏损5300万-7500万由盈转亏 研发费用投入增长",
    "href": "http://stock.jrj.com.cn/2021/01/28224531803700.shtml",
    "datetime": "2021-01-28 22:45:07",
    "code": "002898"
  },
  {
    "title": "赛隆药业：拟转让子公司赛隆国际2%股份",
    "href": "http://stock.jrj.com.cn/2021/01/21083031734216.shtml",
    "datetime": "2021-01-21 08:30:05",
    "code": "002898"
  },
  {
    "title": "赛隆药业(002898.SZ)拟转让珠海赛隆国际投资2%股权",
    "href": "http://stock.jrj.com.cn/2021/01/20162831729118.shtml",
    "datetime": "2021-01-20 16:28:18",
    "code": "002898"
  },
  {
    "title": "赛隆药业：子公司获注射用艾司奥美拉唑钠药品注册书",
    "href": "http://stock.jrj.com.cn/2021/01/08101331653220.shtml",
    "datetime": "2021-01-08 10:13:39",
    "code": "002898"
  },
  {
    "title": "赛隆药业(002898.SZ)：注射用艾司奥美拉唑钠获药品注册证书",
    "href": "http://stock.jrj.com.cn/2021/01/07180631649101.shtml",
    "datetime": "2021-01-07 18:06:26",
    "code": "002898"
  },
  {
    "title": "赛隆药业(002898.SZ)：连续3个交易日收盘价格跌幅偏离值累计超过20%",
    "href": "http://stock.jrj.com.cn/2020/12/29202131597245.shtml",
    "datetime": "2020-12-29 20:21:09",
    "code": "002898"
  },
  {
    "title": "【龙虎榜】赛隆药业12月29日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2020/12/29180131596260.shtml",
    "datetime": "2020-12-29 18:01:00",
    "code": "002898"
  },
  {
    "title": "【龙虎榜】赛隆药业12月28日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2020/12/28180031587249.shtml",
    "datetime": "2020-12-28 18:00:42",
    "code": "002898"
  },
  {
    "title": "【龙虎榜】赛隆药业12月25日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2020/12/25180031571169.shtml",
    "datetime": "2020-12-25 18:00:30",
    "code": "002898"
  },
  {
    "title": "[赛隆药业]国内市场规模超10亿丨赛隆药业注射用帕瑞昔布钠拟中标山东省药品带量采购",
    "href": "http://stock.jrj.com.cn/2020/12/14000031604862.shtml",
    "datetime": "2020-12-14 00:00:00",
    "code": "002898"
  },
  {
    "title": "赛隆药业2020年前三季度亏损2156.88万由盈转亏 产品产销量同比下降",
    "href": "http://stock.jrj.com.cn/2020/10/28141231150561.shtml",
    "datetime": "2020-10-28 14:12:53",
    "code": "002898"
  },
  {
    "title": "赛隆药业(002898.SZ)：控股股东质押1080万股",
    "href": "http://stock.jrj.com.cn/2020/10/23191431118073.shtml",
    "datetime": "2020-10-23 19:14:11",
    "code": "002898"
  },
  {
    "title": "赛隆药业2020年前三季度亏损1800万-2600万 主要产品产销量同比下降",
    "href": "http://stock.jrj.com.cn/2020/10/15114031058789.shtml",
    "datetime": "2020-10-15 11:40:14",
    "code": "002898"
  },
  {
    "title": "赛隆药业：2020年前三季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2020/10/15082031057267.shtml",
    "datetime": "2020-10-15 08:20:01",
    "code": "002898"
  },
  {
    "title": "【龙虎榜】赛隆药业8月17日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2020/08/17180030520537.shtml",
    "datetime": "2020-08-17 18:00:11",
    "code": "002898"
  },
  {
    "title": "赛隆药业2020年上半年亏损1321.3万由盈转亏 药品终端需求明显下降",
    "href": "http://stock.jrj.com.cn/2020/08/12103230480433.shtml",
    "datetime": "2020-08-12 10:32:49",
    "code": "002898"
  },
  {
    "title": "营收净利双降 赛隆药业承压",
    "href": "http://stock.jrj.com.cn/2020/08/12012030476451.shtml",
    "datetime": "2020-08-12 01:20:05",
    "code": "002898"
  },
  {
    "title": "赛隆药业：2020年半年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2020/07/15084030245934.shtml",
    "datetime": "2020-07-15 08:40:05",
    "code": "002898"
  },
  {
    "title": "赛隆药业2020年上半年预计亏损1100万元-1600万元 较上年同期由盈转亏",
    "href": "http://stock.jrj.com.cn/2020/07/15000730242337.shtml",
    "datetime": "2020-07-15 00:07:12",
    "code": "002898"
  },
  {
    "title": "赛隆药业子公司签订《国有建设用地使用权出让合同》 总价3.29亿元",
    "href": "http://stock.jrj.com.cn/2020/07/10191430207005.shtml",
    "datetime": "2020-07-10 19:14:48",
    "code": "002898"
  },
  {
    "title": "赛隆药业子公司3.29亿元拍得珠海建设用地推进公司总部及研究院建设",
    "href": "http://stock.jrj.com.cn/2020/06/30193630099698.shtml",
    "datetime": "2020-06-30 19:36:49",
    "code": "002898"
  },
  {
    "title": "赛隆药业一季度亏损去年扣非净利降7成 西部证券保荐",
    "href": "http://stock.jrj.com.cn/2020/06/04065829841481.shtml",
    "datetime": "2020-06-04 06:58:00",
    "code": "002898"
  },
  {
    "title": "赛隆药业聘任张旭任副总经理",
    "href": "http://stock.jrj.com.cn/2020/06/02190829829060.shtml",
    "datetime": "2020-06-02 19:08:04",
    "code": "002898"
  },
  {
    "title": "[赛隆药业]创造条件,共谋发展——华容县委书记刘铁健莅临公司调研考察",
    "href": "http://stock.jrj.com.cn/2020/05/21000031604861.shtml",
    "datetime": "2020-05-21 00:00:00",
    "code": "002898"
  },
  {
    "title": "赛隆药业：赛隆国际拟竞拍珠海市一宗项目地块 土地挂牌起始价3.29亿元",
    "href": "http://stock.jrj.com.cn/2020/05/19144129711801.shtml",
    "datetime": "2020-05-19 14:41:28",
    "code": "002898"
  },
  {
    "title": "赛隆药业子公司拟参拍土地推进公司总部及研究院建设",
    "href": "http://stock.jrj.com.cn/2020/05/19121829710918.shtml",
    "datetime": "2020-05-19 12:18:20",
    "code": "002898"
  },
  {
    "title": "赛隆药业：子公司门冬氨酸鸟氨酸注射液获批",
    "href": "http://stock.jrj.com.cn/2020/05/14170529672051.shtml",
    "datetime": "2020-05-14 17:05:00",
    "code": "002898"
  },
  {
    "title": "赛隆药业子公司获得门冬氨酸鸟氨酸注射液药品注册批件",
    "href": "http://stock.jrj.com.cn/2020/05/13193929663128.shtml",
    "datetime": "2020-05-13 19:39:36",
    "code": "002898"
  },
  {
    "title": "赛隆药业2020年第一季度亏损756.25万元 由盈转亏 疫情影响",
    "href": "http://stock.jrj.com.cn/2020/05/03140329496582.shtml",
    "datetime": "2020-05-03 14:03:56",
    "code": "002898"
  },
  {
    "title": "赛隆药业2019年净利2748.32万减少54.88% 董事长薪酬36.33万",
    "href": "http://stock.jrj.com.cn/2020/05/03124929494539.shtml",
    "datetime": "2020-05-03 12:49:56",
    "code": "002898"
  },
  {
    "title": "赛隆药业股东蔡南桂质押800万股 用于为公司债券提供反担保",
    "href": "http://stock.jrj.com.cn/2020/04/24215829369950.shtml",
    "datetime": "2020-04-24 21:58:57",
    "code": "002898"
  },
  {
    "title": "赛隆药业和中信城开共同成立项目公司",
    "href": "http://stock.jrj.com.cn/2020/04/20212929331664.shtml",
    "datetime": "2020-04-20 21:29:26",
    "code": "002898"
  },
  {
    "title": "赛隆药业一化合物及药物组合物和制备法获发明专利",
    "href": "http://stock.jrj.com.cn/2020/04/16195129306911.shtml",
    "datetime": "2020-04-16 19:51:38",
    "code": "002898"
  },
  {
    "title": "赛隆药业：“一种右旋艾普拉唑钠化合物及其药物组合物和制备方法”获发明专利 有助于增强公司核心竞争力",
    "href": "http://stock.jrj.com.cn/2020/04/16144129304610.shtml",
    "datetime": "2020-04-16 14:41:30",
    "code": "002898"
  },
  {
    "title": "赛隆药业：2020年第一季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2020/04/15081029292708.shtml",
    "datetime": "2020-04-15 08:10:34",
    "code": "002898"
  },
  {
    "title": "赛隆药业2020年第一季度亏损1250万元–850万元 同比下降497.17%-370.07%",
    "href": "http://stock.jrj.com.cn/2020/04/14201429285898.shtml",
    "datetime": "2020-04-14 20:14:58",
    "code": "002898"
  },
  {
    "title": "[赛隆药业]优势互补 强强合作 赛隆药业 中信城开合作总部项目成功签约",
    "href": "http://stock.jrj.com.cn/2020/04/10000031604860.shtml",
    "datetime": "2020-04-10 00:00:00",
    "code": "002898"
  },
  {
    "title": "赛隆药业与中信城开签订《总部项目合作协议》",
    "href": "http://stock.jrj.com.cn/2020/04/08222329239897.shtml",
    "datetime": "2020-04-08 22:23:15",
    "code": "002898"
  },
  {
    "title": "赛隆药业全资子公司为公司2020年1.5亿元非公开发行公司债券提供反担保",
    "href": "http://stock.jrj.com.cn/2020/03/23193329085259.shtml",
    "datetime": "2020-03-23 19:33:48",
    "code": "002898"
  },
  {
    "title": "赛隆药业签订《项目投资协议书》 预计项目投资不低于10445元/平方米",
    "href": "http://stock.jrj.com.cn/2020/03/19225729063976.shtml",
    "datetime": "2020-03-19 22:57:39",
    "code": "002898"
  },
  {
    "title": "赛隆药业：与珠海市香洲区投资促进服务中心签订项目投资协议书",
    "href": "http://stock.jrj.com.cn/2020/03/19194029062951.shtml",
    "datetime": "2020-03-19 19:40:00",
    "code": "002898"
  },
  {
    "title": "赛隆药业全资子公司拟申请6500万元综合授信额度 赛隆生物提供抵押担保",
    "href": "http://stock.jrj.com.cn/2020/03/11204629003279.shtml",
    "datetime": "2020-03-11 20:46:57",
    "code": "002898"
  },
  {
    "title": "赛隆药业2019年净利3040万元下滑50% 受药品招投标降价",
    "href": "http://stock.jrj.com.cn/2020/02/27233228909510.shtml",
    "datetime": "2020-02-27 23:32:26",
    "code": "002898"
  },
  {
    "title": "赛隆药业拟在珠海香洲区投建公司总部及研究院",
    "href": "http://stock.jrj.com.cn/2020/02/21204828873456.shtml",
    "datetime": "2020-02-21 20:48:27",
    "code": "002898"
  },
  {
    "title": "赛隆药业拟申请4000万元综合授信额度 蔡南桂和唐霖提供担保",
    "href": "http://stock.jrj.com.cn/2020/02/15095628832706.shtml",
    "datetime": "2020-02-15 09:56:56",
    "code": "002898"
  },
  {
    "title": "赛隆药业向一线医护人员捐赠药品及款项",
    "href": "http://stock.jrj.com.cn/2020/02/12222328817978.shtml",
    "datetime": "2020-02-12 22:23:51",
    "code": "002898"
  },
  {
    "title": "赛隆药业捐赠450万元现金及物资驰援抗击疫情",
    "href": "http://stock.jrj.com.cn/2020/02/12195328817417.shtml",
    "datetime": "2020-02-12 19:53:00",
    "code": "002898"
  },
  {
    "title": "赛隆药业捐赠现金及药品450万元抗击疫情",
    "href": "http://stock.jrj.com.cn/2020/02/12182128816690.shtml",
    "datetime": "2020-02-12 18:21:00",
    "code": "002898"
  },
  {
    "title": "[赛隆药业]赛隆药业捐赠胸腺法新等药品为一线战“疫”人员保驾护航共抗疫情,赛隆药业在行动",
    "href": "http://stock.jrj.com.cn/2020/02/12000031604859.shtml",
    "datetime": "2020-02-12 00:00:00",
    "code": "002898"
  },
  {
    "title": "[赛隆药业]白衣天使出征注射胸腺法新 双成药业、安科生物、赛隆药业等公司生产",
    "href": "http://stock.jrj.com.cn/2020/02/08000031604858.shtml",
    "datetime": "2020-02-08 00:00:00",
    "code": "002898"
  },
  {
    "title": "赛隆药业：2019年年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2020/01/21073028710577.shtml",
    "datetime": "2020-01-21 07:30:01",
    "code": "002898"
  },
  {
    "title": "赛隆药业全资子公司拟向银行申请6500万元项目开发贷款",
    "href": "http://stock.jrj.com.cn/2020/01/20225428708562.shtml",
    "datetime": "2020-01-20 22:54:20",
    "code": "002898"
  },
  {
    "title": "赛隆药业预计2019年盈利2526万元至3662万元 同比减少40%至59%",
    "href": "http://stock.jrj.com.cn/2020/01/20213728708197.shtml",
    "datetime": "2020-01-20 21:37:06",
    "code": "002898"
  },
  {
    "title": "赛隆药业全资子公司收到华容县政府技术扶持资金825万元",
    "href": "http://stock.jrj.com.cn/2020/01/01231628614312.shtml",
    "datetime": "2020-01-01 23:16:39",
    "code": "002898"
  },
  {
    "title": "赛隆药业两注射剂新药获批 有望增厚公司业绩",
    "href": "http://stock.jrj.com.cn/2019/12/29194328599988.shtml",
    "datetime": "2019-12-29 19:43:11",
    "code": "002898"
  },
  {
    "title": "赛隆药业：子公司获得药品注册批件",
    "href": "http://stock.jrj.com.cn/2019/12/29153228599684.shtml",
    "datetime": "2019-12-29 15:32:14",
    "code": "002898"
  },
  {
    "title": "赛隆药业：子公司获得药品注册批件",
    "href": "http://stock.jrj.com.cn/2019/12/27160028596965.shtml",
    "datetime": "2019-12-27 16:00:16",
    "code": "002898"
  },
  {
    "title": "赛隆药业注射用替加环素获批 业绩迎新增长点",
    "href": "http://stock.jrj.com.cn/2019/12/26183928591515.shtml",
    "datetime": "2019-12-26 18:39:39",
    "code": "002898"
  },
  {
    "title": "[赛隆药业]赛隆药业:注射用替加环素获批 业绩迎新增长点",
    "href": "http://stock.jrj.com.cn/2019/12/26000031604856.shtml",
    "datetime": "2019-12-26 00:00:00",
    "code": "002898"
  },
  {
    "title": "[赛隆药业]【瞩目】3大重磅注射剂,赛隆药业即将入局",
    "href": "http://stock.jrj.com.cn/2019/12/23000031604855.shtml",
    "datetime": "2019-12-23 00:00:00",
    "code": "002898"
  },
  {
    "title": "[赛隆药业]傲立寒冬,耀动山城 ——赛隆药业亮相第82届全国药品交易会",
    "href": "http://stock.jrj.com.cn/2019/12/07000031604854.shtml",
    "datetime": "2019-12-07 00:00:00",
    "code": "002898"
  },
  {
    "title": "赛隆药业取得了国家知识产权局颁发的发明专利证书",
    "href": "http://stock.jrj.com.cn/2019/11/07170928366319.shtml",
    "datetime": "2019-11-07 17:09:58",
    "code": "002898"
  },
  {
    "title": "赛隆药业2019年前三季度净利1687.7万–2485.39万 药品招投标降价",
    "href": "http://stock.jrj.com.cn/2019/10/15132928249462.shtml",
    "datetime": "2019-10-15 13:29:47",
    "code": "002898"
  },
  {
    "title": "赛隆药业：2019年前三季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2019/10/15091028247730.shtml",
    "datetime": "2019-10-15 09:10:01",
    "code": "002898"
  },
  {
    "title": "赛隆药业副总经理唐霖辞职 2018年薪酬为25万元",
    "href": "http://stock.jrj.com.cn/2019/10/11212328235296.shtml",
    "datetime": "2019-10-11 21:23:26",
    "code": "002898"
  },
  {
    "title": "赛隆药业股东质押1170万股 2019年上半年净利同比下滑41%",
    "href": "http://stock.jrj.com.cn/2019/09/08200528105575.shtml",
    "datetime": "2019-09-08 20:05:22",
    "code": "002898"
  },
  {
    "title": "赛隆药业子公司获药品GMP证书",
    "href": "http://stock.jrj.com.cn/2019/09/06211828102827.shtml",
    "datetime": "2019-09-06 21:18:12",
    "code": "002898"
  },
  {
    "title": "芬太尼概念股直线拉升 赛隆药业、景峰医药双双涨停",
    "href": "http://stock.jrj.com.cn/2019/09/03102028081586.shtml",
    "datetime": "2019-09-03 10:20:50",
    "code": "002898"
  },
  {
    "title": "赛隆药业2019年上半年净利2022万 毛利率明显下滑",
    "href": "http://stock.jrj.com.cn/2019/08/30143428062493.shtml",
    "datetime": "2019-08-30 14:34:57",
    "code": "002898"
  },
  {
    "title": "赛隆药业注射用帕瑞昔布钠获药品注册批件",
    "href": "http://stock.jrj.com.cn/2019/08/13203627971260.shtml",
    "datetime": "2019-08-13 20:36:18",
    "code": "002898"
  },
  {
    "title": "赛隆药业全资子公司获得注射用帕瑞昔布钠《药品注册批件》",
    "href": "http://stock.jrj.com.cn/2019/08/13133527969294.shtml",
    "datetime": "2019-08-13 13:35:03",
    "code": "002898"
  },
  {
    "title": "午间公告：广电运通预中标中国邮政邮储项目；赛隆药业获药品注册批件",
    "href": "http://stock.jrj.com.cn/2019/08/13120327968994.shtml",
    "datetime": "2019-08-13 12:03:00",
    "code": "002898"
  },
  {
    "title": "赛隆药业新获一发明专利",
    "href": "http://stock.jrj.com.cn/2019/06/11224227688348.shtml",
    "datetime": "2019-06-11 22:42:52",
    "code": "002898"
  },
  {
    "title": "赛隆药业：实控人提议2018年10派2元",
    "href": "http://stock.jrj.com.cn/2019/05/16170527582144.shtml",
    "datetime": "2019-05-16 17:05:21",
    "code": "002898"
  },
  {
    "title": "赛隆药业：实控人提议2018年度10派2元",
    "href": "http://stock.jrj.com.cn/2019/05/16165227582091.shtml",
    "datetime": "2019-05-16 16:52:22",
    "code": "002898"
  },
  {
    "title": "赛隆药业2019年第一季度净利315万元 董事长蔡南桂上年末持股8183万股",
    "href": "http://stock.jrj.com.cn/2019/04/24074927471979.shtml",
    "datetime": "2019-04-24 07:49:04",
    "code": "002898"
  },
  {
    "title": "赛隆药业去年营收4.36亿同比增长20% 董事长蔡南桂薪酬31万",
    "href": "http://stock.jrj.com.cn/2019/04/24061827471034.shtml",
    "datetime": "2019-04-24 06:18:50",
    "code": "002898"
  },
  {
    "title": "赛隆药业：2019年第一季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2019/03/29181027268007.shtml",
    "datetime": "2019-03-29 18:10:00",
    "code": "002898"
  },
  {
    "title": "赛隆药业一复合物研发获国家发明专利",
    "href": "http://stock.jrj.com.cn/2019/03/28133927258116.shtml",
    "datetime": "2019-03-28 13:39:49",
    "code": "002898"
  },
  {
    "title": "赛隆药业：全资子公司2055万元竞得长沙市望城区地块",
    "href": "http://stock.jrj.com.cn/2019/03/04180627115760.shtml",
    "datetime": "2019-03-04 18:06:54",
    "code": "002898"
  },
  {
    "title": "赛隆药业：取得发明专利证书",
    "href": "http://stock.jrj.com.cn/hotstock/2019/02/19075927060815.shtml",
    "datetime": "2019-02-19 07:59:59",
    "code": "002898"
  },
  {
    "title": "赛隆药业：全资子公司拟参与竞拍土地使用权",
    "href": "http://stock.jrj.com.cn/hotstock/2019/02/18080027053774.shtml",
    "datetime": "2019-02-18 08:00:00",
    "code": "002898"
  },
  {
    "title": "赛隆药业：子公司获氨甲环酸注射液药品注册批件",
    "href": "http://stock.jrj.com.cn/hotstock/2019/01/08075926870946.shtml",
    "datetime": "2019-01-08 07:59:59",
    "code": "002898"
  },
  {
    "title": "赛隆药业：2018年年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2018/10/30023025274495.shtml",
    "datetime": "2018-10-30 02:30:00",
    "code": "002898"
  },
  {
    "title": "赛隆药业：关于首次公开发行前已发行股份上市流通的提示性公告",
    "href": "http://stock.jrj.com.cn/2018/09/10195025071332.shtml",
    "datetime": "2018-09-10 19:50:00",
    "code": "002898"
  },
  {
    "title": "赛隆药业：2018年前三季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2018/08/27201025007180.shtml",
    "datetime": "2018-08-27 20:10:03",
    "code": "002898"
  },
  {
    "title": "赛隆药业：获注射用赖氨匹林药品注册批件",
    "href": "http://stock.jrj.com.cn/2018/06/27164024735120.shtml",
    "datetime": "2018-06-27 16:40:00",
    "code": "002898"
  },
  {
    "title": "赛隆药业长沙研发中心取得发明专利证书",
    "href": "http://stock.jrj.com.cn/2018/05/31202824620491.shtml",
    "datetime": "2018-05-31 20:28:36",
    "code": "002898"
  },
  {
    "title": "赛隆药业：控股股东提议利润分配",
    "href": "http://stock.jrj.com.cn/2018/05/17182024554868.shtml",
    "datetime": "2018-05-17 18:20:00",
    "code": "002898"
  },
  {
    "title": "赛隆药业2017年度营收同比增42%",
    "href": "http://stock.jrj.com.cn/2018/04/22232624428547.shtml",
    "datetime": "2018-04-22 23:26:04",
    "code": "002898"
  },
  {
    "title": "赛隆药业：2018年半年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2018/04/22203024428297.shtml",
    "datetime": "2018-04-22 20:30:00",
    "code": "002898"
  },
  {
    "title": "赛隆药业：一季度净利预增逾三倍",
    "href": "http://stock.jrj.com.cn/2018/03/29163024322490.shtml",
    "datetime": "2018-03-29 16:30:00",
    "code": "002898"
  },
  {
    "title": "赛隆药业吸引人才煞费苦心 不惜耗资近半亿买房“栓人”",
    "href": "http://stock.jrj.com.cn/2018/02/01165024046118.shtml",
    "datetime": "2018-02-01 16:50:00",
    "code": "002898"
  },
  {
    "title": "赛隆药业：逾4200万元购买48套商品房 用作人才房",
    "href": "http://stock.jrj.com.cn/2018/02/01163524045903.shtml",
    "datetime": "2018-02-01 16:35:53",
    "code": "002898"
  },
  {
    "title": "赛隆药业：2017年年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2017/10/19225023258789.shtml",
    "datetime": "2017-10-19 22:50:00",
    "code": "002898"
  },
  {
    "title": "新股提示：赛隆药业、银都股份今日申购",
    "href": "http://stock.jrj.com.cn/2017/08/30072523026277.shtml",
    "datetime": "2017-08-30 07:25:00",
    "code": "002898"
  },
  {
    "title": "新股提醒:银都股份、赛隆药业申购 兆丰股份中签缴款",
    "href": "http://stock.jrj.com.cn/ipo/2017/08/30065023026095.shtml",
    "datetime": "2017-08-30 06:50:19",
    "code": "002898"
  },
  {
    "title": "赛隆药业获准IPO 产能利用率低 新产能如何消化？",
    "href": "http://stock.jrj.com.cn/2017/08/01025322823794.shtml",
    "datetime": "2017-08-01 02:53:15",
    "code": "002898"
  },
  {
    "title": "珠海赛隆药业股份有限公司首次公开发行股票招股说明书（申报稿2017年7月13日报送）",
    "href": "http://stock.jrj.com.cn/2017/07/14172122750895.shtml",
    "datetime": "2017-07-14 17:21:56",
    "code": "002898"
  }
]